Follow
ALISAN KAYABOLEN
ALISAN KAYABOLEN
Postdoctoral Associate, MIT
Verified email at mit.edu
Title
Cited by
Cited by
Year
Native extracellular matrix/fibroin hydrogels for adipose tissue engineering with enhanced vascularization
A Kayabolen, D Keskin, A Aykan, Y Karslıoglu, F Zor, A Tezcaner
Biomedical Materials 12 (3), 035007, 2017
702017
IDH Mutations in Glioma: Double-Edged Sword in Clinical Applications?
A Kayabolen, E Yilmaz, T Bagci-Onder
Biomedicines 9 (7), 799, 2021
502021
The pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme
E Kaya-Aksoy, A Cingoz, F Senbabaoglu, F Seker, I Sur-Erdem, ...
Cell death discovery 5 (1), 64, 2019
392019
The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies
S Durdagi, T Avsar, MD Orhan, M Serhatli, BK Balcioglu, HU Ozturk, ...
Molecular Therapy 30 (2), 963-974, 2022
242022
The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma
E Ozyerli-Goknar, I Sur-Erdem, F Seker, A Cingöz, A Kayabolen, ...
Cell Death & Disease 10 (12), 894, 2019
242019
Programmable RNA-guided DNA endonucleases are widespread in eukaryotes and their viruses
K Jiang, J Lim, S Sgrizzi, M Trinh, A Kayabolen, N Yutin, W Bao, K Kato, ...
Science Advances 9 (39), eadk0171, 2023
102023
Protein Scaffold‐Based Multimerization of Soluble ACE2 Efficiently Blocks SARS‐CoV‐2 Infection In Vitro and In Vivo
A Kayabolen, U Akcan, D Özturan, H Ulbegi‐Polat, GN Sahin, ...
Advanced Science 9 (27), 2201294, 2022
102022
EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities
O Yedier-Bayram, B Gokbayrak, A Kayabolen, AC Aksu, AD Cavga, ...
Cell Death & Disease 13 (8), 710, 2022
92022
In vitro/in vivo comparison of cefuroxime release from poly(ε‐caprolactone)–calcium sulfate implants for osteomyelitis treatment
V Yaprakci, O Erdemli, A Kayabolen, A Tezcaner, F Bozkurt, D Keskin
Biotechnology and Applied Biochemistry 60 (6), 603-616, 2013
72013
Characterization and discrimination of spike protein in SARS‐CoV‐2 virus‐like particles via surface‐enhanced Raman spectroscopy
M Akdeniz, Z Al‐Shaebi, M Altunbek, C Bayraktar, A Kayabolen, ...
Biotechnology Journal 19 (1), 2300191, 2024
32024
Combined inhibition of KDM6A/B and HDACs exacerbates integrated stress response and mediates therapeutic effects in IDH1-mutant glioma
A Kayabolen, GN Sahin, F Seker-Polat, A Cingoz, B Isik, S Acar, ...
bioRxiv, 2020
22020
Development of vascularized adipose tissue construct based on adipose tissue extracellular matrix and silk fibroin
A Kayabölen
Middle East Technical University, 2015
22015
Programmable rna writing using crispr effectors and trans-splicing templates
OO Abudayyeh, JS Gootenberg, W Zhou, A Kayabolen, CF Schmitt-Ulms
US Patent App. 18/455,380, 2024
2024
Programmable RNA writing with trans-splicing
C Schmitt-Ulms, A Kayabolen, M Manero-Carranza, N Zhou, K Donnelly, ...
bioRxiv, 2024.01. 31.578223, 2024
2024
ACE2-Coated Virus-Like Particles Effectively Block SARS-CoV-2 Infection
C Bayraktar, A Kayabolen, A Odabas, A Durgun, I Kok, K Sevinc, ...
bioRxiv, 2023.09. 19.558424, 2023
2023
Overcoming chemoresistance in triple negative breast cancer by bromodomain inhibition
O Yedier-Bayram, A Cingoz, AC Aksu, N Pinarbasi-Degirmenci, B Esin, ...
European Journal of Cancer 174, S69, 2022
2022
CRISPRa-mediated induction of apoptosis in therapy-resistant glioblastoma cells via derepression of pro-apoptotic genes
E Yilmaz, A Kayabolen, SC Atalar, B Yigit, B Ulukan, M Zeybel, ...
Cancer Research 82 (12_Supplement), 6255-6255, 2022
2022
Re-establishment of fertilization competency of the oocyte via CRISPR/dCas9 epigenome edition technology
GN Sahin, G Soyler, A Kayabolen, A Kocabay, AC Taskin, ...
HUMAN REPRODUCTION 36, 395-396, 2021
2021
P–567 Re-establishment of fertilization competency of the oocyte via CRISPR/dCas9 epigenome edition technology
GN Sahin, G Soyler, A Kayabolen, A Kocabay, AC Taskın, ...
Human Reproduction 36 (Supplement_1), deab130. 566, 2021
2021
Protein scaffold-based multimerization of soluble ACE2 efficiently blocks SARS-CoV-2 infection in vitro (preprint)
A Kayabolen, U Akcan, D Ozturan, E Sarayloo, E Nurtop, B Ozer, ...
2021
The system can't perform the operation now. Try again later.
Articles 1–20